Torbjørn Bjerke, MD

Stockholm, Sweden
Torbjörn Bjerke, MD PhD, has served as a member of SynAct Board of Directors since 2016 and as the CEO since May, 2023. Most recently, Dr Bjerke was the portfolio manager of Arctic Aurora LifeScience. He previously served as the president and CEO of Karolinska Development AB from 2011 to 2014. Prior to that, Dr Bjerke was the president and CEO of Orexo AB, a position he held from 2007 until January 2011. Previously, he was president and CEO of Biolipox AB, Executive Vice President, R&D, ALK Pharmaceuticals, and director of pharmacology at AstraZeneca. Dr Bjerke holds a PhD in medicine from Aarhus Universitet.
Speaking In
11:30 AM - 11:45 AM
Tuesday, June 6
SynAct Pharma AB is a clinical stage biotechnology company focused on the resolution of…
Session Room 104C